Shakya, Needa ShresthaGurubacharya, Simmi MisraAryal, Dhana Raj2026-06-122026-06-122010https://hdl.handle.net/20.500.14572/6477Needa Shrestha Shakya Medical Officer, NICU, Maternity Hospital (Prasuti Griha), Kathmandu Simmi Misra Gurubacharya Registrar, NICU, Maternity Hospital (Prasuti Griha), Kathmandu Dhana Raj Aryal Consultant Paediatrician and Neonatologist, NICU, Maternity Hospital (Prasuti Griha), KathmanduAbstract: A term baby born to an epileptic mother who was treated with Phenytoin until 10weeks of pregnancy was born with multiple congenital anomalies and diagnosed to have Fetal Hydantoin Syndrome. Infants of mothers who have taken hydantoin during pregnancy have been found to have broad multisystem patterns of abnormalities, including mental retardation, craniofacial anomalies, nail and digital hypoplasia and prenatal onset of growth deficiency. The discussion aims to bring to attention the potential hazard of the use of hydantoin drug during reproductive age to all medical practitioners.en-USCongenital anomaliesepilepsyfetal hydantoin syndromephenytoinArticle